Dr Sarah Jackson works with Dr Mark Wills in the Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID) which is part of the Department of Medicine in the University of Cambridge. Our group is particularly interested in understanding the immune responses to human cytomegalovirus (HCMV) during both the lytic and latent phases of infections and how these responses are modulated by HCMV in different cohorts of people including healthy donors, transplant patients and older people.